IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BIO-RAD LABORATORIES (NYSE: BIO) | Delayed: 363.50 +3.00 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $360.50 | 52 Week High | $174.02 | |||
| Open | $359.83 | 52 Week Low | $122.03 | |||
| Day High | $367.93 | P/E | 117.64 | |||
| Day Low | $359.83 | EPS | $3.09 | |||
| Volume | 228,224 | |||||
| (NASDAQ: IMDX) | Delayed: 2.84 -0.18 (5.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.02 | 52 Week High | $ | |||
| Open | $2.94 | 52 Week Low | $ | |||
| Day High | $2.99 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $ | |||
| Volume | 262,006 | |||||
